Cisplatin nephrotoxicity and protection by milk thistle extract in rats

被引:84
作者
Karimi, G [1 ]
Ramezani, M [1 ]
Tahoonian, Z [1 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynamy & Toxicol, Mashhad 91775, Iran
关键词
cisplatin; milk thistle; renal toxicity; silymarin;
D O I
10.1093/ecam/neh103
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The protective effect of methanolic extract of milk thistle seeds and silymarin against cisplatin-induced renal toxicity in male rats after a single intraperitoneal injection of 3 mg kg(-1) cisplatin were studied. Over 5 days, cisplatin-treated rats showed tubular necrosis and elevation in blood urea nitrogen ( BUN) and serum creatinine (Scr). Pretreatment of animals with silymarin (50 mg kg(-1)) or extract (0.6 g kg(-1)) 2 h before cisplatin prevented the tubular damage. Rats treated with silymarin or extract 2 h after cisplatin had BUN and Scr significantly lower than those receiving cisplatin, but mild to moderate necrosis was observed. These results suggested that milk thistle may protect against cisplatin-induced renal toxicity and might serve as a novel combination agent with cisplatin to limit renal injury.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 23 条
[1]  
Antunes LMG, 2000, PHARMACOL RES, V41, P405, DOI 10.1006/phrs.1999.0600
[2]   In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity [J].
Baliga, R ;
Zhang, ZW ;
Baliga, M ;
Ueda, N ;
Shah, SV .
KIDNEY INTERNATIONAL, 1998, 53 (02) :394-401
[3]  
Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20
[4]  
DERMARDEROSIAN A, 2001, REV NATURAL PRODUCT, P405
[5]  
Fleming T, 2000, PDR HERBAL MED, P516
[6]  
Gaedeke J, 1996, NEPHROL DIAL TRANSPL, V11, P55
[7]  
Hammersen F, 1985, HISTOLOGY, P1
[8]   FLAVONOIDS, A CLASS OF NATURAL-PRODUCTS OF HIGH PHARMACOLOGICAL POTENCY [J].
HAVSTEEN, B .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (07) :1141-1148
[9]   ATTENUATION OF CISPLATINUM-INDUCED NEPHROTOXICITY IN THE RAT BY HIGH SALT DIET, FUROSEMIDE AND ACETAZOLAMIDE [J].
HEIDEMANN, HT ;
GERKENS, JF ;
JACKSON, EK ;
BRANCH, RA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (02) :201-205
[10]  
JONES TW, 1985, LAB INVEST, V52, P363